Table 1 Baseline clinical characteristics of the study group
Characteristics | Number of patients | Percentage (%) |
|---|---|---|
Number of patients | 80 | 100 |
Age (years) | ||
Mean | 58.5 | |
Range | 38-70 | |
Gender | ||
Male | 48 | 60.0 |
Female | 32 | 40.0 |
KPS | ||
90-100 | 63 | 78.7 |
80 | 17 | 21.3 |
AJCC clinical stage | ||
IIIA | 35 | 43.8 |
IIIB | 45 | 56.2 |
Histology | ||
Adenocarcinoma | 31 | 38.8 |
Squamous cell | 43 | 53.8 |
Large cell carcinoma | 3 | 3.7 |
Other | 3 | 3.7 |
Tumor site (lobe) | ||
Upper & middle | 57 | 71.2 |
Lower | 23 | 28.8 |
Comorbidity | ||
COPD | 7 | 8.8 |
Cardiovascular disease | 3 | 3.7 |
Diabetes | 3 | 3.7 |
Smoking history | ||
Nonsmoker | 34 | 42.5 |
Current or ex smoker | 46 | 57.5 |
Chemotherapy | ||
Yes | 56 | 70 |
No | 24 | 30 |
V20 | ||
Mean | 32.11 | |
Range | 8.6-63.3 | |
V30 | ||
Mean | 29.5 | |
Range | 6.6-48.5 | |
Weight loss ≥ 5% | ||
Yes | 29 | 36.2 |
No | 51 | 63.8 |